Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 2/20 | 0.67 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.67 |
| ▸ | GPR84 | Q9NQS5 | 8/20 | 0.62 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | FDPS | P14324 | 3/20 | 0.54 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.54 |
| ▸ | PSMD14 | O00487 | 2/20 | 0.52 |
| ▸ | PLA2G1B | P04054 | 2/20 | 0.52 |
| ▸ | MMP2 | P08253 | 2/20 | 0.52 |
| ▸ | ATG4B | Q9Y4P1 | 2/20 | 0.52 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.52 |
| ▸ | RAD52 | P43351 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2926826 | 1.00 | FFAR1 (0.67) | FFAR1FFAR4GPR84NFKB1LMNA | |
| SCHEMBL4651686 | 1.00 | FFAR1 (0.67) | FFAR1FFAR4GPR84NFKB1LMNA | |
| SCHEMBL865728 | 1.00 | FFAR1 (0.67) | FFAR1FFAR4GPR84NFKB1LMNA | |
| SCHEMBL7203318 | 1.00 | FFAR1 (0.67) | FFAR1FFAR4GPR84NFKB1LMNA | |
| SCHEMBL17336081 | 1.00 | FFAR1 (0.67) | FFAR1FFAR4GPR84NFKB1LMNA | |
| SCHEMBL23789287 | 1.00 | FFAR1 (0.67) | FFAR1FFAR4GPR84NFKB1LMNA | |
| SCHEMBL9308592 | 1.00 | FFAR1 (0.67) | FFAR1FFAR4GPR84NFKB1LMNA | |
| SCHEMBL6934264 | 1.00 | FFAR1 (0.67) | FFAR1FFAR4GPR84NFKB1LMNA | |
| SCHEMBL1687517 | 1.00 | FFAR1 (0.67) | FFAR1FFAR4GPR84NFKB1LMNA | |
| SCHEMBL4956318 | 1.00 | FFAR1 (0.67) | FFAR1FFAR4GPR84NFKB1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 86 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119233757-A | Agricultural composition | 奥罗农业欧洲股份公司 | 2024-12-31 | — | — | CN | claimed |
| CN-118994284-A | Gemcitabine prodrug or pharmaceutically acceptable salt thereof containing side chains with different flexibilities, self-assembled nanoparticle thereof and application | 沈阳药科大学 | 2024-11-22 | — | — | CN | claimed |
| CN-117327085-A | SN 38-fatty alcohol prodrug, self-assembled nanoparticle thereof and application thereof | 沈阳药科大学 | 2024-01-02 | — | — | CN | claimed |
| US-20170369816-A1 | COLD-WATER LAUNDRY DETERGENTS | STEPAN CO (US) | 2017-12-28 | — | — | US | claimed |
| CN-106574209-A | Detergent for cold water cleaning | 斯泰潘公司 | 2017-04-19 | — | — | CN | claimed |
| US-20170066998-A1 | DETERGENTS FOR COLD-WATER CLEANING | STEPAN COMPANY | 2017-03-09 | — | — | US | claimed |
| WO-2026101900-A1 | NOVEL HYDROXY CYCLOALKYL CONTAINING LIPID COMPOUNDS AND METHODS OF THEIR USE | Acuitas Therapeutics, Inc. (CA) | 2026-05-15 | — | — | WO | disclosed |
| CN-117327085-B | SN 38-fatty alcohol prodrug, self-assembled nanoparticle thereof and application thereof | 沈阳药科大学 | 2026-05-15 | — | — | CN | disclosed |
| EP-4727913-A1 | LIPIDS FOR USE IN LIPID NANOPARTICLES | Acuitas Therapeutics, Inc. (CA) | 2026-04-22 | — | — | EP | disclosed |
| WO-2025226377-A1 | AGRICULTURAL COMPOSITION | ORO AGRI INC. (US) | 2025-10-30 | — | — | WO | disclosed |
| US-20250249123-A1 | LIPIDS AND COMPOSITIONS THEREOF | GENERATION BIO CO. | 2025-08-07 | — | — | US | disclosed |
| US-20250161432-A1 | CATIONIC LIPID COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF | HIGHFIELD BIOPHARMACEUTICALS CORPORATION (CN) | 2025-05-22 | — | — | US | disclosed |
| EP-4541785-A1 | CATIONIC LIPID COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF | Highfield Biopharmaceuticals Corporation (CN) | 2025-04-23 | — | — | EP | disclosed |
| US-20060014702-A1 | Antimicrobial agent | GRIFFITH UNIVERSITY (AU) | 2006-01-19 | — | — | US | disclosed |
| CN-1653076-A | An antimicrobial agent | UNIV GRIFFITH (AU) | 2005-08-10 | — | — | CN | disclosed |
| EP-1506213-A1 | AN ANTIMICROBIAL AGENT | GRIFFITH UNIVERSITY (AU) | 2005-02-16 | — | — | EP | disclosed |
| WO-2003097657-A9 | AN ANTIMICROBIAL AGENT | UNIV GRIFFITH (AU) | 2004-03-11 | — | — | WO | disclosed |
| WO-2003097657-A1 | AN ANTIMICROBIAL AGENT | GRIFFITH UNIVERSITY (AU) | 2003-11-27 | — | — | WO | disclosed |
| US-5112471-A | Polymer, a nitrophenyl ether plastizer, quaternary ammonium or phosphonium salt | HITACHI, LTD. (JP) | 1992-05-12 | — | — | US | disclosed |
| EP-0339613-A2 | Ion selective electrode | HITACHI, LTD. (JP) | 1989-11-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060014702-A1 | Antimicrobial agent | FUT6, LGALS1, FUT5 | FFAR1 2459/4885FFAR4 2205/4885GPR84 2582/4885 |
| US-20250161432-A1 | CATIONIC LIPID COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF | CETP, NPC1L1, PCTP | FFAR1 90/4885FFAR4 71/4885GPR84 2643/4885 |
| US-20250249123-A1 | LIPIDS AND COMPOSITIONS THEREOF | C1R, LIPG, LRBA | FFAR1 303/4885FFAR4 1210/4885GPR84 1884/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.